Becton, Dickinson and Company
Medical technology company
Based in NJ
AI Overview
With $1.2M in lobbying spend across 19 quarterly filings, Becton, Dickinson and Company is a significant lobbying presence. Their lobbying covers 1 issue area. Active from 2021 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $200K |
| 2022 | $400K |
| 2023 | $300K |
| 2024 | $240K |
| 2025 | $100K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Becton, Dickinson and Company disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
Issues of interest to manufacturer and direct supplier of medical products
COVID testing
Implementation of the American Rescue Plan, Public Law 117-2, and federal funding for COVID testing; issues affecting manufacturer and direct supplier of medical products
Implementation of the American Rescue Plan, Public Law 117-2 and federal funding for COVID testing; issues affecting manufacturer and direct supplier of medical products
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.